Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005
Epidemiology and Infection, Volume 136, No. 8, Year 2008
Notification
URL copied to clipboard!
Description
Introduction of pneumococcal conjugate and polysaccharide vaccines into the United Kingdom's routine immunization programmes is expected to change the epidemiology of invasive pneumococcal disease (IPD). We have documented the epidemiology of IPD in an English region (South West) with high-quality surveillance data before these programmes were established. We analysed data on isolates of Streptococcus pneumoniae from blood and CSF between 1996 and 2005 from microbiology laboratories in the South West that were reported and/or referred for serotyping to the Health Protection Agency Centre for Infections. The mean annual incidence of IPD increased from 11.2/100 000 in 1996 to 13.6/100 000 in 2005 (P < 0.04). After adjusting for annual blood-culture sampling rates in hospitals serving the same catchment populations, an increase in annual incidence of IPD was no longer observed (P = 1.0). Variation in overall incidence between laboratories could also be explained by variation in blood culture rates. The proportion of disease caused by serotypes 6B, 9V and 14 decreased significantly (P = 0.001, P = 0.007, and P = 0.027 respectively) whereas that caused by serotype 4, 7F and 1 increased (P = 0.001, P = 0.003, and P < 0.001 respectively) between 2000 and 2005. The level of penicillin non-susceptibility and resistance to erythromycin remained stable (2% and 12% respectively). This study provides an important baseline to assess the impact of changing vaccination programmes on the epidemiology of IPD, thus informing future use of pneumococcal vaccines. © 2007 Cambridge University Press.
Authors & Co-Authors
Ihekweazu, Chikwe A.
United Kingdom, London
Public Health England
Dance, David Allan Brett
United Kingdom, London
Public Health England
Pebody, Richard G.
United Kingdom, London
Public Health England
George, Robert C.
United Kingdom, London
Public Health England
Smith, Michael D.
United Kingdom, Taunton
Somerset Nhs Foundation Trust
Waight, Pauline A.
United Kingdom, London
Public Health England
Stuart, James Mac Naughton
United Kingdom, London
Public Health England
Statistics
Citations: 27
Authors: 7
Affiliations: 2
Identifiers
Doi:
10.1017/S0950268807009715
ISSN:
14694409
Research Areas
Maternal And Child Health
Study Design
Cohort Study